Skip to main content

Thomas Werth, M.D.

Contact Information

Phone Numbers

Appointment: (585) 275-4711

Office: (585) 275-4711


I see and treat patients representing the full spectrum of digestive and liver diseases, including providing a diagnosis and workup for gastrointestinal and liver cancer. My areas of expertise include gastroenterology and transplant hepatology.

Conditions I Treat:

- Gastrointestinal cancers
- Liver cancer

Professional Background

Dr. Werth is an Associate Professor of Clinical Medicine and the Medical Director of the Gastroenterology, Hepatology and Endoscopy at UR Sawgrass and serves as the Associate Program Director of the Gastroenterology Fellowship training program. He attended medical school at University of Kansas, Kansas City. He did his internship, residency and fellowship at Beth Israel Hospital, Harvard, Boston. Dr. Werth is board certified in Internal Medicine, Gastroenterology and Transplant Hepatology. Dr. Werth has previously held faculty appointments with medical schools in Texas and North Carolina. He assisted with the establishment of the liver transplant program in Charlotte and is experienced in the care of patients with advanced hepatobiliary and gastrointestinal disease. He has participated in a number of clinical research trials including treatments of Hepatitis C Inflammatory Bowel Disease, Cirrhosis and IBS.



BA | University of Kansas

M.D. | University of Kansas Medical School

Post-doctoral Training & Residency

07/01/1988 - 06/30/1990
Fellowship in Gastroenterology at Beth Israel Deaconess Medical Center-Main Campus

07/01/1986 - 06/30/1988
Residency in Internal Medicine at Beth Israel Deaconess Medical Center-Main Campus

06/17/1985 - 06/30/1986
Internship in Internal Medicine at Beth Israel Deaconess Medical Center-Main Campus

VIEW ALL expand_more


Journal Articles

Sprung B, Werth T, Huber AR. "An Unusual Cause of Gastritis." Gastroenterology.. 2016 Nov; 151(5):e11-e12. Epub 2016 Oct 06.

Bertagnolli MM, Hsu M, Hawk ET, Eagle CJ, Zauber AG, . "Statin use and colorectal adenoma risk: results from the adenoma prevention with celecoxib trial." Cancer prevention research.. 2010 May; 3(5):588-96. Epub 2010 Apr 19.

Bertagnolli MM, Eagle CJ, Zauber AG, Redston M, Breazna A, Kim K, Tang J, Rosenstein RB, Umar A, Bagheri D, Collins NT, Burn J, Chung DC, Dewar T, Foley TR, Hoffman N, Macrae F, Pruitt RE, Saltzman JR, Salzberg B, Sylwestrowicz T, Hawk ET, . "Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial." Cancer prevention research.. 2009 Apr; 2(4):310-21. Epub 2009 Mar 31.